Proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received a 3rd dose of was 84.0% in 2024. ▲ Rising
Proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), 2008–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) is 84.0%, measured in 2024.
That represents a change of up 31.2% over ten years.
Over the whole period, proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) peaked at 85.0% in 2019 and was at its lowest, 37.0%, in 2008.
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th of 37 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 17 years of available data.
Proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 37.0% | — |
| 2009 | 40.0% | +8.1% |
| 2010 | 52.0% | +30.0% |
| 2011 | 62.0% | +19.2% |
| 2012 | 63.0% | +1.6% |
| 2013 | 64.0% | +1.6% |
| 2014 | 64.0% | +0.0% |
| 2015 | 65.0% | +1.6% |
| 2016 | 71.0% | +9.2% |
| 2017 | 78.0% | +9.9% |
| 2018 | 82.0% | +5.1% |
| 2019 | 85.0% | +3.7% |
| 2020 | 83.0% | -2.4% |
| 2021 | 83.0% | +0.0% |
| 2022 | 84.0% | +1.2% |
| 2023 | 84.0% | +0.0% |
| 2024 | 84.0% | +0.0% |
Biggest year-on-year movements
Years where Proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +30.0% | 40.0% | 52.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 38.5% | 37.0% | 40.0% | 2 |
| 2010s | 68.6% | 52.0% | 85.0% | 10 |
| 2020s | 83.6% | 83.0% | 84.0% | 5 |
Countries ranked near Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
More infrastructure data for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
- Proportion of the target population who received 3 doses of 94.0% (2024)
- Developing countries’ and least developed countries’ share of global 55.7% (2024)
- Developing countries’ and least developed countries’ share of global 51.7% (2024)
- Developing countries’ and least developed countries’ share of global 64.2% (2024)
- Developing countries’ and least developed countries’ share of global 68.5% (2024)
- Total official flows for infrastructure, by recipient countries 6,728 (2024)
- Proportion of the target population who received 91.0% (2024)
- Container port traffic, maritime transport 221.66 million (2024)
- Proportion of tariff lines applied to imports with zero-tariff 56.8% (2024)
- Data Infrastructure performance index (Statistical Performance) 83.33 (2024)
Frequently asked questions
- What is proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Proportion of the target population who received a 3rd dose of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) was 84.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest proportion of the target population who received a 3rd dose of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- The highest recorded value was 85.0% in 2019.
- What is the lowest proportion of the target population who received a 3rd dose of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- The lowest recorded value was 37.0% in 2008.
- How does Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank for proportion of the target population who received a 3rd dose of?
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th out of 37 groups with data for 2024.
- Is proportion of the target population who received a 3rd dose of rising or falling in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Over the last ten years it is up 31.2%. The long-run trend across the full record is rising.
- Where does this Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under UN SDG Global Database (open, attribution requested).